Organization
Morphotek
3 clinical trials
Clinical trial
A Phase I Study of the Safety, Tolerability, and Pharmacokinetics of MORAb-066, a Humanized Monoclonal Antibody to Human Tissue Factor, in Patients With Advanced or Metastatic Breast, Pancreatic, Colorectal, or Non-Small Cell Lung Cancer (Adenocarcinoma) MalignanciesStatus: Completed, Estimated PCD: 2016-02-09
Clinical trial
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With MesotheliomaStatus: Completed, Estimated PCD: 2011-06-30
Clinical trial
A Randomized, Double-blind, Placebo-Controlled, Phase 3 Study to Assess the Efficacy and Safety of Weekly Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Subjects With Platinum-sensitive Ovarian Cancer in First RelapseStatus: Terminated, Estimated PCD: 2012-12-31